UK bans puberty blockers for minors
- March 13, 2024
- 0
He British National Health Service vetoed puberty blockers in gender identity clinics around the country. These drugs are used to interrupt physical changes during puberty, such as breast
He British National Health Service vetoed puberty blockers in gender identity clinics around the country. These drugs are used to interrupt physical changes during puberty, such as breast
He British National Health Service vetoed puberty blockers in gender identity clinics around the country. These drugs are used to interrupt physical changes during puberty, such as breast development or facial hair, and are used in minors with gender dysphoria.
The measure was taken after public consultation and an internal review of health system practices and is based on the findings of an independent investigation, which concluded that “there is insufficient evidence to support the safety and clinical effectiveness of puberty inhibitors, so such treatment is generally available.” For now, these drugs will be used only experimentally.
The government called the decision historic and said the National Health Service “must ensure that gender identity services protect, support and act in the best interests of children”.
I met parents in Fareham who felt let down by the NHS, with teenage children prescribed puberty blockers but later regretting it.
It turned out that they did not want an irreversible gender change.
This is real progress in the protection, health and well-being of children. https://t.co/ANqnpiiUTI
— Suella Braverman, MP (@SuellaBraverman) March 12, 2024
“I have met parents in Fareham who felt let down by the NHS – their teenage children were given puberty blockers and then regretted it. It turns out that they did not want an irreversible gender change. This is about real breakthrough for the protection, health and well-being of children,” said former minister Inside, Suella Braverman.
For our part, from the team LGTBQ+ expressed concern about this policy. They believe that “all trans youth deserve access to timely, quality health care” and that these inhibitors are an important part of that care.
Radio France International
Source: Aristegui Noticias
As an experienced journalist and author, Mary has been reporting on the latest news and trends for over 5 years. With a passion for uncovering the stories behind the headlines, Mary has earned a reputation as a trusted voice in the world of journalism. Her writing style is insightful, engaging and thought-provoking, as she takes a deep dive into the most pressing issues of our time.